Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Feasibility of Specimen Self-collection in Young Children Undergoing SARS-CoV-2 Surveillance for In-Person Learning.
Altamirano J, Lopez M, Robinson IG, Chun LX, Tam GK, Shaikh NJ, Hoyte EG, Carrington YJ, Jani SG, Toomarian EY, Hsing JC, Ma J, Pulendran U, Govindarajan P, Blomkalns AL, Pinsky BA, Wang CJ, Maldonado Y. Altamirano J, et al. Among authors: hoyte eg. JAMA Netw Open. 2022 Feb 1;5(2):e2148988. doi: 10.1001/jamanetworkopen.2021.48988. JAMA Netw Open. 2022. PMID: 35175340 Free PMC article.
Case report: Refractory Evans syndrome in two patients with spondyloenchondrodysplasia with immune dysregulation treated successfully with JAK1/JAK2 inhibition.
Gernez Y, Narula M, Cepika AM, Valdes Camacho J, Hoyte EG, Mouradian K, Glader B, Singh D, Sathi B, Rao L, Tolin AL, Weinberg KI, Lewis DB, Bacchetta R, Weinacht KG. Gernez Y, et al. Among authors: hoyte eg. Front Immunol. 2024 Jan 29;14:1328005. doi: 10.3389/fimmu.2023.1328005. eCollection 2023. Front Immunol. 2024. PMID: 38347954 Free PMC article. Review.
Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab.
Bégin P, Dominguez T, Wilson SP, Bacal L, Mehrotra A, Kausch B, Trela A, Tavassoli M, Hoyte E, O'Riordan G, Blakemore A, Seki S, Hamilton RG, Nadeau KC. Bégin P, et al. Among authors: hoyte e. Allergy Asthma Clin Immunol. 2014 Feb 20;10(1):7. doi: 10.1186/1710-1492-10-7. Allergy Asthma Clin Immunol. 2014. PMID: 24576338 Free PMC article.
Safety and feasibility of oral immunotherapy to multiple allergens for food allergy.
Bégin P, Winterroth LC, Dominguez T, Wilson SP, Bacal L, Mehrotra A, Kausch B, Trela A, Hoyte E, O'Riordan G, Seki S, Blakemore A, Woch M, Hamilton RG, Nadeau KC. Bégin P, et al. Among authors: hoyte e. Allergy Asthma Clin Immunol. 2014 Jan 15;10(1):1. doi: 10.1186/1710-1492-10-1. Allergy Asthma Clin Immunol. 2014. PMID: 24428859 Free PMC article.
Erratum to: Safety and feasibility of oral immunotherapy to multiple allergens for food allergy.
Bégin P, Winterroth LC, Dominguez T, Wilson SP, Bacal L, Mehrotra A, Kausch B, Trela A, Hoyte E, O'Riordan G, Seki S, Blakemore A, Woch M, Hamilton RG, Nadeau KC. Bégin P, et al. Among authors: hoyte e. Allergy Asthma Clin Immunol. 2016 May 24;12:28. doi: 10.1186/s13223-016-0133-1. eCollection 2016. Allergy Asthma Clin Immunol. 2016. PMID: 27222658 Free PMC article.
15 results